Finance

Lists
Why is ERMA down 6,57%?
Dive Deeper
ERMA:STO
Enorama Pharma AB
0,63 SEK
-6,57%
(-0,044) 1D
5-окт., 17:00:00 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ERMA...
Open
0,63 SEK
High
0,63 SEK
Low
0,63 SEK
Mkt. cap
46,69 млн
Avg. vol.
117,38 миң
Volume
1,00 миң
52-wk high
3,00 SEK
52-wk low
0,21 SEK
EPS
-0,80 SEK
Shares outstanding
74,59 млн
No. of employees
4
Open
0,63 SEK
High
0,63 SEK
Low
0,63 SEK
Mkt. cap
46,69 млн
Avg. vol.
117,38 миң
Volume
1,00 миң
52-wk high
3,00 SEK
52-wk low
0,21 SEK
EPS
-0,80 SEK
Shares outstanding
74,59 млн
No. of employees
4
News stories
From web sources and news partners
About Enorama Pharma AB
CEOMats Rönngard
Employees4
Founded2006
Headquarters-
SectorPharmaceutical industry
Websiteenorama.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-193,00 миң
1,75 млн
-108,00 миң
-
Cost of goods sold
1,07 млн
5,28 млн
-58,00 миң
-
Cost of revenue
1,07 млн
5,28 млн
-58,00 миң
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,91 млн
14,68 млн
11,99 млн
11,62 млн
Operating expense
11,07 млн
14,24 млн
12,51 млн
11,84 млн
Total operating expenses
12,15 млн
19,52 млн
12,45 млн
11,84 млн
Operating income
-12,34 млн
-17,77 млн
-12,56 млн
-11,84 млн
Other non operating income
-
-8,00 миң
1,68 млн
137,00 миң
EBT including unusual items
-13,35 млн
-20,57 млн
-12,64 млн
-13,12 млн
EBT excluding unusual items
-13,35 млн
-20,57 млн
-12,64 млн
-13,12 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
78,00 миң
-539,00 миң
424,00 миң
131,00 миң
Net income
-13,35 млн
-20,57 млн
-12,64 млн
-13,12 млн
Net profit margin
6 915,03%
-1 175,66%
11 708,33%
-
Earnings per share
-
-
-
-
Interest and investment income
-
9,08 млн
1,51 млн
630,00 миң
Interest expense
-1,01 млн
-
-3,28 млн
-2,04 млн
Net interest expenses
-1,01 млн
9,08 млн
-1,77 млн
-1,41 млн
Depreciation and amortization charges
89,00 миң
92,00 миң
90,00 миң
90,00 миң
EBITDA
-12,34 млн
-17,68 млн
-12,47 млн
-11,75 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору